Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 8/20 | 0.50 |
| ▸ | MMP9 | P14780 | 8/20 | 0.50 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 3/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4072013 | 0.81 | KAT6A (0.45) | CYP3A4 | |
| SCHEMBL14572900 | 0.79 | MMP2 (0.55) | MMP2MMP9MMP14TP53MMP3 | |
| SCHEMBL5745852 | 0.78 | BCHE (0.42) | MMP2MMP9MMP14TP53BCHE | |
| SCHEMBL16789640 | 0.77 | FFAR4 (0.45) | MMP2MMP9MMP14TP53BCHE | |
| SCHEMBL2377118 | 0.77 | MMP2 (0.54) | MMP2MMP9MMP14TP53MMP3 | |
| SCHEMBL7967599 | 0.77 | MMP1 (0.47) | BCHEACHEMMP1KIF11MAPT | |
| SCHEMBL4071220 | 0.77 | PKM (0.54) | MMP2MMP9MMP13MMP1MEN1 | |
| SCHEMBL17376377 | 0.77 | ALDH1A1 (0.40) | TP53MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL22056762 | 0.76 | DDR1 (0.40) | TP53BCHEACHEKIF11MEN1 | |
| SCHEMBL31514006 | 0.76 | DDR1 (0.40) | TP53BCHEACHEKIF11MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4251285-A1 | HAIR COLORING COMPOSITIONS | Wella International Operations Switzerland Sàrl (CH) | 2023-10-04 | — | — | EP | disclosed |
| EP-4225264-A1 | COSMETIC COMPOSITIONS AND USES THEREOF | Coty Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-4225256-A1 | COSMETIC COMPOSITIONS AND USES THEREOF | Coty Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022112473-A1 | HAIR COLORING COMPOSITIONS | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2022-06-02 | — | — | WO | disclosed |
| EP-3773923-A1 | HAIR TREATMENT COMPOSITIONS, SYSTEMS, DEVICES AND METHODS | HFC Prestige International Holding Switzerland S.a.r.l. (CH) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019199779-A1 | HAIR TREATMENT COMPOSITIONS, SYSTEMS, DEVICES AND METHODS | MUNIZ DENA (US) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019161360-A1 | SYSTEM FOR CUSTOMIZING HAIR DYE FORMULATIONS | COTY INC. (US) | 2019-08-22 | — | — | WO | disclosed |
| EP-3515561-A1 | METHODS AND KITS FOR COLORING HAIR | Noxell Corporation (US) | 2019-07-31 | — | — | EP | disclosed |
| EP-3512488-A1 | HAIR COLOR COMPOSITIONS COMPRISING STABLE VIOLET-BLUE TO BLUE IMIDAZOLIUM DYES | Noxell Corporation (US) | 2019-07-24 | — | — | EP | disclosed |
| WO-2019074736-A1 | KERATIN DYEING COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND METHOD AND USE THEREOF | NOXELL CORPORATION (US) | 2019-04-18 | — | — | WO | disclosed |
| US-20080113944-A1 | Novel Indole Derivatives | NOVO NORDISK A/S (DK) | 2008-05-15 | — | — | US | disclosed |
| EP-1758856-A2 | INDOLE DERIVATIVES FOR THE TREATMENT OF OBESITY | NOVO NORDISK A/S (DK) | 2007-03-07 | — | — | EP | disclosed |
| US-20060128662-A1 | Novel compounds for treatment of obesity | NOVO NORDISK A/S (DK) | 2006-06-15 | — | — | US | disclosed |
| EP-1625112-A1 | NOVEL COMPOUNDS FOR TREATMENT OF OBESITY | NOVO NORDISK A/S (DK) | 2006-02-15 | — | — | EP | disclosed |
| WO-2005105785-A2 | INDOLE DERIVATIVES FOR TREATMENT OF OBESITY | NOVO NORDISK A/S (DK) | 2005-11-10 | — | — | WO | disclosed |
| WO-2004101505-A1 | NOVEL COMPOUNDS FOR TREATMENT OF OBESITY | NOVO NORDISK A/S (DK) | 2004-11-25 | — | — | WO | disclosed |
| CN-1118468-C | Pyrazolopyrimidines and pyrazolotriazines | HOFFMANN LA ROCHE (CH) | 2003-08-20 | — | — | CN | disclosed |
| US-6194410-B1 | ANTISEROTONINE AGENTS; NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS | HOFFMAN-LA ROCHE INC. | 2001-02-27 | — | — | US | disclosed |
| CN-1236780-A | Pyrazolopyrimidines and pyrazolotriazines | HOFFMANN LA ROCHE (CH) | 1999-12-01 | — | — | CN | disclosed |
| EP-0941994-A1 | Pyrazolopyrimidines and pyrazolotriazines with 5-HT6 receptor affinity | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080113944-A1 | Novel Indole Derivatives | GPR119, FABP4, MC4R | MMP2 3765/4885MMP9 4558/4885MMP14 3783/4885 |
| US-20060128662-A1 | Novel compounds for treatment of obesity | GPR119, FABP4, HSD17B4 | MMP2 1587/4885MMP9 4280/4885MMP14 3254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.